Elixinol Wellness Limited
ELLXF
$0.01
$0.01248.78%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.45M | 2.40M | 2.67M | 2.74M | 2.23M |
| Total Other Revenue | 7.40K | 7.20K | -- | -- | -- |
| Total Revenue | 2.46M | 2.40M | 2.67M | 2.74M | 2.23M |
| Cost of Revenue | 1.61M | 1.57M | 1.71M | 1.76M | 1.46M |
| Gross Profit | 849.40K | 831.80K | 958.20K | 985.30K | 770.70K |
| SG&A Expenses | 1.61M | 1.57M | 1.45M | 1.49M | 1.44M |
| Depreciation & Amortization | 163.70K | 160.30K | 164.50K | 169.20K | 176.90K |
| Other Operating Expenses | 114.70K | 112.30K | 132.30K | 136.00K | 44.80K |
| Total Operating Expenses | 3.49M | 3.42M | 3.45M | 3.55M | 3.13M |
| Operating Income | -1.04M | -1.02M | -786.50K | -808.70K | -894.60K |
| Income Before Tax | -990.70K | -970.10K | -832.80K | -856.30K | -907.70K |
| Income Tax Expenses | -- | -- | -1.17M | -1.20M | 300.00 |
| Earnings from Continuing Operations | -990.70K | -970.10K | 336.90K | 346.40K | -908.10K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -990.70K | -970.10K | 336.90K | 346.40K | -908.10K |
| EBIT | -1.04M | -1.02M | -786.50K | -808.70K | -894.60K |
| EBITDA | -915.10K | -896.10K | -697.30K | -716.90K | -717.60K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 222.16M | 222.16M | 184.36M | 184.36M | 124.74M |
| Average Diluted Shares Outstanding | 222.16M | 222.16M | 184.36M | 184.36M | 124.74M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |